相似文献
1
Development and evaluation of safety and effectiveness of novel cancer screening tests for routine clinical use with applications to multicancer detection technologies.
Cancer. 2022 Feb 15;128 Suppl 4(Suppl 4):883-891. doi: 10.1002/cncr.33954.
2
Multicancer Early Detection Technologies: A Review Informed by Past Cancer Screening Studies.
Cancer Epidemiol Biomarkers Prev. 2022 Jun 1;31(6):1139-1145. doi: 10.1158/1055-9965.EPI-21-1443.
3
Considerations in the implementation of multicancer early detection tests.
Future Oncol. 2022 Sep;18(28):3119-3124. doi: 10.2217/fon-2022-0120. Epub 2022 Sep 5.
4
Primary care physicians and laypersons' perceptions of multicancer detection clinical trial designs.
JNCI Cancer Spectr. 2024 Sep 2;8(5). doi: 10.1093/jncics/pkae084.
5
Cancer screening with multicancer detection tests: A translational science review.
CA Cancer J Clin. 2024 Jul-Aug;74(4):368-382. doi: 10.3322/caac.21833. Epub 2024 Mar 22.
6
Testing Whether Cancer Screening Saves Lives: Implications for Randomized Clinical Trials of Multicancer Screening.
JAMA Intern Med. 2023 Nov 1;183(11):1255-1258. doi: 10.1001/jamainternmed.2023.3781.
7
Multicancer early detection test: Preclinical, translational, and clinical evidence-generation plan and provocative questions.
Cancer. 2022 Feb 15;128 Suppl 4:861-874. doi: 10.1002/cncr.33912.
8
Perspectives of primary care providers regarding multicancer early detection panels.
Einstein (Sao Paulo). 2024 Aug 23;22:eAO0771. doi: 10.31744/einstein_journal/2024AO0771. eCollection 2024.
9
Examining developments in multicancer early detection: highlights of new clinical data from recent conferences.
Am J Manag Care. 2021 Dec;27(19 Suppl):S347-S355. doi: 10.37765/ajmc.2021.88801.
10
Study design considerations for trials to evaluate multicancer early detection assays for clinical utility.
J Natl Cancer Inst. 2023 Mar 9;115(3):250-257. doi: 10.1093/jnci/djac218.
引用本文的文献
1
Liquid biopsy-based multi-cancer early detection: an exploration road from evidence to implementation.
Sci Bull (Beijing). 2025 Sep 15;70(17):2852-2867. doi: 10.1016/j.scib.2025.06.030. Epub 2025 Jun 24.
2
Circulating tumor DNA in clinical trials for solid tumors: Challenges and current applications.
J Liq Biopsy. 2023 Aug 29;1:100007. doi: 10.1016/j.jlb.2023.100007. eCollection 2023 Sep.
3
FIT as a Comparator for Evaluating the Effectiveness of New Non-invasive CRC Screening Test.
Dig Dis Sci. 2024 Nov 19. doi: 10.1007/s10620-024-08718-w.
4
The multitarget fecal immunochemical test versus the fecal immunochemical test for programmatic colorectal cancer screening: a cross-sectional intervention study with paired design.
BMC Cancer. 2022 Dec 12;22(1):1299. doi: 10.1186/s12885-022-10372-2.
本文引用的文献
1
Clinical validation of a targeted methylation-based multi-cancer early detection test using an independent validation set.
Ann Oncol. 2021 Sep;32(9):1167-1177. doi: 10.1016/j.annonc.2021.05.806. Epub 2021 Jun 24.
2
Screening for Colorectal Cancer: US Preventive Services Task Force Recommendation Statement.
JAMA. 2021 May 18;325(19):1965-1977. doi: 10.1001/jama.2021.6238.
3
Screening for Lung Cancer: US Preventive Services Task Force Recommendation Statement.
JAMA. 2021 Mar 9;325(10):962-970. doi: 10.1001/jama.2021.1117.
4
Sensitive and specific multi-cancer detection and localization using methylation signatures in cell-free DNA.
Ann Oncol. 2020 Jun;31(6):745-759. doi: 10.1016/j.annonc.2020.02.011. Epub 2020 Mar 30.
5
The National Cancer Institute Early Detection Research Network: Two Decades of Progress.
Cancer Epidemiol Biomarkers Prev. 2020 Dec;29(12):2396-2400. doi: 10.1158/1055-9965.EPI-20-1158.
6
Should This Patient Be Screened for Pancreatic Cancer? : Grand Rounds Discussion From Beth Israel Deaconess Medical Center.
Ann Intern Med. 2020 Dec 1;173(11):914-921. doi: 10.7326/M20-6384.
7
Adding Rigor to Biomarker Evaluations-EDRN Experience.
Cancer Epidemiol Biomarkers Prev. 2020 Dec;29(12):2575-2582. doi: 10.1158/1055-9965.EPI-20-0240. Epub 2020 Nov 10.
8
Non-invasive early detection of cancer four years before conventional diagnosis using a blood test.
Nat Commun. 2020 Jul 21;11(1):3475. doi: 10.1038/s41467-020-17316-z.
9
Developing Primary Care-Based Recommendations for Social Determinants of Health: Methods of the U.S. Preventive Services Task Force.
Ann Intern Med. 2020 Sep 15;173(6):461-467. doi: 10.7326/M20-0730. Epub 2020 Jul 14.
10
Pitfalls in Cancer Biomarker Discovery and Validation with Emphasis on Circulating Tumor DNA.
Cancer Epidemiol Biomarkers Prev. 2020 Dec;29(12):2568-2574. doi: 10.1158/1055-9965.EPI-20-0074. Epub 2020 Apr 10.
Zotero 插件